U.S. FDA informs Biocon Biologics of deferred... ... Market Live Updates Today: The Indian stock market is expected to open in the green as trends on SGX Nifty indicate a positive opening for the index in India with a 43 points gain.

U.S. FDA informs Biocon Biologics of deferred action on the Biologics License Application (BLA) for MYL-14020, a proposed biosimilar to Avastin. Due to travel restrictions the agency is unable to conduct an inspection during the current review cycle.

Update: 2020-12-28 05:45 GMT

Linked news